Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with systemic lupus erythematosus stratified by disease duration

Molecular Medicine

Volumn 17, Issue 11, 2011, Pages 1349-1356

  Mackay, Meggan ^a   Bussa, Mathew P ^a   Aranow, Cynthia ^a   Uluǧ, Aziz M ^a   Volpe, Bruce T ^a   Huerta, Patricio T ^a   Argyelan, Miklos ^a   Mande, Arthur ^b   Hirsch, Joy ^b   Diamond, Betty ^a   Eidelberg, David ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BOLD SIGNAL; BRAIN FUNCTION; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE DURATION; ELECTROENCEPHALOGRAM; FACIAL EXPRESSION; FEAR; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SOMATOSENSORY CORTEX; SYSTEMIC LUPUS ERYTHEMATOSUS; TASK PERFORMANCE; WORKING MEMORY;

ADULT; BRAIN; BRAIN MAPPING; FACE; FEAR; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; ORGAN SPECIFICITY; TASK PERFORMANCE AND ANALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 82855168126     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2011.00185     Document Type: Article

References (61)

1. Caronti B, et al. (1998) Anti-beta 2-glycoprotein I antibodies bind to central nervous system. J. Neurol. Sci. 156:211-9.
2. DeGiorgio LA, et al. (2001) A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7:1189-93.
3. Kent MN, et al. (2000) Ultrastructural localization of monoclonal antiphospholipid antibody binding to rat brain. Exp. Neurol. 163:173-9.
4. Matus S, et al. (2007) Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. J. Exp. Med. 204:3221-34.
5. Ndhlovu M, et al. (2011) Identification of alphatubulin as an autoantigen recognized by sera from patients with neuropsychiatric systemic lupus erythematosus. Brain Behav. Immun. 25:279-85.
6. Arinuma Y, Yanagida T, Hirohata S. (2008) Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 58:1130-5.
7. Fragoso-Loyo H, et al. (2008) Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus: implications for diagnosis and pathogenesis. PLoS One. 3:e3347.
8. Hirohata S, et al. (2007) Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res. Ther. 9:R44.
9. Yoshio T, et al. (2006) Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 54:675-8.
10. Huerta PT, et al. (2006) Immunity and behavior: antibodies alter emotion. Proc. Natl. Acad. Sci. U. S. A. 103:678-83.
11. Kowal C, et al. (2006) Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl. Acad. Sci. U. S. A. 103:19854-9.
12. Faust TW, et al. (2010) Neurotoxic lupus auto - antibodies alter brain function through two distinct mechanisms. Proc. Natl. Acad. Sci. U. S. A. 107:18569-74.
13. George-Chandy A, Trysberg E, Eriksson K. (2008) Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms. Arthritis Res. Ther. 10:R97.
14. Hirohata S, Miyamoto T. (1990) Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum. 33:644-9.
15. Katsumata Y, et al. (2007) Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin. J. Rheumatol. 34:2010-7.
16. Trysberg E, Carlsten H, Tarkowski A. (2000) Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus. 9:498-503.
17. Banks WA, Erickson MA. (2010) The blood-brain barrier and immune function and dysfunction. Neurobiol. Dis. 37:26-32.
18. Carvey PM, Hendey B, Monahan AJ. (2009) The blood-brain barrier in neurodegenerative disease: a rhetorical perspective. J. Neurochem. 111:291-314.
19. Hawkins BT, et al. (2004) Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res. 1027:48-58.
20. Diamond B, et al. (2009) Losing your nerves? Maybe it's the antibodies. Nat. Rev. Immunol. 9:449-56.
21. Gladman DD, et al. (1997) The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum. 1997. 40:809-13.
22. Nossent JC. (1998) SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis. J. Rheumatol. 25:654-9.
23. Gladman DD, Urowitz MB. (1999) The SLICC/ ACR damage index: progress report and experience in the field. Lupus. 8:632-7.
24. DiFrancesco MW, et al. (2007) Functional magnetic resonance imaging assessment of cognitive function in childhood-onset systemic lupus erythematosus: a pilot study. Arthritis Rheum. 56:4151-63.
25. Fitzgibbon BM, et al. (2008) Functional MRI in NPSLE patients reveals increased parietal and frontal brain activation during a working memory task compared with controls. Rheumatology (Oxford). 47:50-3.
26. Rocca MA, et al. (2006) An fMRI study of the motor system in patients with neuropsychiatric systemic lupus erythematosus. Neuroimage. 30:478-84.
27. Bombardier C, et al. (1992) Derivation of the SLEDAI: a disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35:630-40.
28. Ozawa S, Kamiya H, Tsuzuki K. (1998) Glutamate receptors in the mammalian central nervous system. Prog. Neurobiol. 54:581-618.
29. Sternberg S. (1966) High-speed scanning in human memory. Science. 153:652-4.
30. Etkin A, et al. (2004) Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron. 44:1043-55.
31. Ekman P, Friesen WV. (1976) Pictures of Facial Affect. Palo Alto, CA: Consulting Psychologists.
32. Friston KJ, et al. (1995) Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapp. 2:189-210.
33. Maldjian JA, et al. (2003) An automated method for neuroanatomic and cytoarchitectonic atlasbased interrogation of fMRI data sets. Neuroimage. 19:1233-9.
34. Carbon M, et al. (2008) Increased cerebellar activation during sequence learning in DYT1 carriers: an equiperformance study. Brain. 131:146-54.
35. Mentis MJ, et al. (2003) Enhancement of brain activation during trial-and-error sequence learning in early PD. Neurology. 60:612-9.
36. Petri M, et al. (2008) Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus. J. Rheumatol. 35:2348-54.
37. Bobholz JA, et al. (2006) fmri study of episodic memory in relapsing-remitting MS: correlation with T2 lesion volume. Neurology. 67:1640-5.
38. Rocca MA, et al. (2002) Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage. Ann. Neurol. 51:330-9.
39. Yetkin FZ, et al. (2006) FMRI of working memory in patients with mild cognitive impairment and probable Alzheimer's disease. Eur. Radiol. 16:193-206.
40. Karni A, et al. (1998) The acquisition of skilled motor performance: fast and slow experiencedriven changes in primary motor cortex. Proc. Natl. Acad. Sci. U. S. A. 95:861-8.
41. Calautti C, Baron JC. (2003) Functional neuro - imaging studies of motor recovery after stroke in adults: a review. Stroke. 34:1553-66.
42. Emmer BJ, et al. (2006) Selective involvement of the amygdala in systemic lupus erythematosus. PLoS Med. 3:e499.
43. Cavanna AE, Trimble MR. (2006) The precuneus: a review of its functional anatomy and behavioural correlates. Brain. 129:564-83.
44. Cabeza R, et al. (2004) Task-independent and task-specific age effects on brain activity during working memory, visual attention and episodic retrieval. Cereb. Cortex. 14:364-75.
45. Rajah MN, D'Esposito M. (2005) Region-specific changes in prefrontal function with age: a review of PET and fMRI studies on working and episodic memory. Brain. 128:1964-83.
46. de Kloet ER, Oitzl MS, Joels M. (1999) Stress and cognition: are corticosteroids good or bad guys? Trends Neurosci. 22:422-6.
47. de Quervain DJ, Roozendaal B, McGaugh JL. (1998) Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature. 394:787-90.
48. Brown ES, et al. (2004) Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol. Psychiatry. 55:538-45.
49. Keenan PA, et al. (1995) Commonly used therapeutic doses of glucocorticoids impair explicit memory. Ann. N. Y. Acad. Sci. 761:400-2.
50. McEwen BS. (1998) Protective and damaging effects of stress mediators. N. Engl. J. Med. 338:171-9.
51. Sapolsky RM. (2000) Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry. 57:925-35.
52. Young AH, et al. (1999) The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology (Berl). 145:260-6.
53. Appenzeller S, et al. (2007) Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus. Neuroimage. 34:694-701.
54. Holsboer F, Barden N. (1996) Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr. Rev. 17:187-205.
55. Lupien SJ, McEwen BS. (1997) The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res. Brain Res. Rev. 24:1-27.
56. Ginsburg KS, et al. (1992) A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum. 35:776-82.
57. Hanly JG, et al. (1992) Cognitive impairment in patients with systemic lupus erythematosus. J. Rheumatol. 19:562-7.
58. Hay EM, et al. (1994) A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus. Ann. Rheum. Dis. 53:298-303.
59. Kozora E, et al. (1996) Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum. 39:2035-45.
60. Papero PH, et al. (1990) Neuropsychologic deficits and antineuronal antibodies in pediatric systemic lupus erythematosus. Clin. Exp. Rheumatol. 8:417-24.
61. Waterloo K, et al. (2001) Neuropsychological dysfunction in systemic lupus erythematosus is not associated withchanges in cerebral blood flow. J. Neurol. 248:595-602.